The DOI matches its Crossref record; the references it cites are not checked yet.
Immunoglobulin A and liver diseases
Open accessAbstract
Immunoglobulin A (IgA) is a major immunoglobulin isotype in the gut and plays a role in maintenance of gut homeostasis. Secretory IgA (SIgA) has multiple functions in the gut, such as to regulate microbiota composition, to protect intestinal epithelium from pathogenic microorganisms, and to help for immune-system development. The liver is the front-line organ that receives gut-derived products through the portal vein, implying that the liver could be severely affected by a disrupted intestinal homeostasis. Indeed, some liver diseases like alcoholic liver disease are associated with an altered composition of gut microbiota and increased blood endotoxin levels. Therefore, deficiency of SIgA function appears as a significant factor for the pathogenesis of liver diseases associated with altered gut microbiome. In this review, we describe SIgA functions on the gut microbiome and discuss the role of IgA for liver diseases, especially alcoholic liver disease and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, further studies have shown a role of IgA in liver diseases, such as alcohol-related liver disease and NAFLD/NASH27.”
From Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling (2023) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 124 · Cited by 76
Metadata
- Authors
- Inamine, T., & Schnabl, B.
- Affiliations
- Nagasaki University (JP)
- University of California San Diego (US)
- Corresponding author
- Inamine, Tatsuo
- Schnabl, Bernd
- Venue
- Journal of Gastroenterology
- Published
- 2017-10-26
- Volume
- 53
- Issue
- 6
- Pages
- 691-700
- ISSN
- 0944-1174 (ISSN-L)
- 1435-5922
- PMC
- PMC5971039
- OpenAlex
- W2765688209
- Cited by
- 76
- References
- 124
- Citations by year
- 2026: 11 · 2025: 12 · 2024: 11 · 2023: 8 · 2022: 12 · 2021: 6 · 2020: 8 · 2019: 4 · 2018: 4
- FWCI
- 0.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Journal of Gastroenterology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- Japan Society for the Promotion of Science (17K15953)
- National Institute on Alcohol Abuse and Alcoholism (R01 AA020703, U01 AA24726, U01 AA021856)
- Biomedical Laboratory Research and Development, VA Office of Research and Development (I01BX002213)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- secretory IgA, immunoglobulin A, liver disease, gut microbiota, intestinal homeostasis, alcoholic liver disease, non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, endotoxin, gut-liver axis, intestinal epithelium
- MeSH terms
- Gastrointestinal Microbiome, Humans, Immunoglobulin A, Secretory, Intestines, Liver Diseases, Liver Diseases, Alcoholic, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immunoglobulin A and liver diseases. https://app.cochat.ai/papers/10.1007/s00535-017-1400-8
- The paper
- Inamine, T., & Schnabl, B. (2018). Immunoglobulin A and liver diseases. Journal of Gastroenterology. https://doi.org/10.1007/s00535-017-1400-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.